SureTrader Advertisement PRTC
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: YankeeDolphin, 1~Eye~Jack!!, zoomboom, JJAAMMAANN, Rosym, $tock~$crooge!!
Search This Board:
Last Post: 5/29/2016 11:49:03 AM - Followers: 734 - Board type: Free - Posts Today: 1

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

info@amarantus.com
pr@amarantus.com


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 

 
 
                                                                            

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
AMBS News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 05/16/2016 05:55:11 PM
AMBS News: Annual Report (10-k) 05/16/2016 04:14:23 PM
AMBS News: Current Report Filing (8-k) 04/21/2016 04:21:56 PM
AMBS News: Notification That Annual Report Will Be Submitted Late (nt 10-k) 03/30/2016 05:40:56 PM
AMBS News: Proxy Soliciting Materials (revised) (prer14a) 03/14/2016 05:30:37 PM
PostSubject
#123648  Sticky Note AMBS...BIG BOOM...When the Door Closes... JJAAMMAANN 03/09/16 02:22:12 PM
#124868   Funny because no one at the company knows SidVicious 05/29/16 11:49:03 AM
#124866   That's not really shocking is it? They have Inoviorulez 05/28/16 08:52:40 PM
#124864   Eltropazine - stalled... JPetroInc 05/28/16 07:21:25 PM
#124863   such a great pipe JPetroInc 05/28/16 07:01:05 PM
#124861   RS looming on back of ESS PR? JPetroInc 05/28/16 11:23:26 AM
#124860   latest Tweet from @G_Troll_Commiss @ Meg Tirrell unfolds JPetroInc 05/28/16 10:58:28 AM
#124858   with SeeThru conference scheduled for Tuesday in JPetroInc 05/27/16 02:38:01 PM
#124857   yeah, right JPetroInc 05/27/16 12:40:08 PM
#124856   Is it? When? The start date? Gerald the SidVicious 05/27/16 12:15:30 PM
#124855   ESS is entering Phase 2 clinical studies under newflow 05/27/16 12:09:14 PM
#124854   Gerald is a joke JPetroInc 05/27/16 11:38:27 AM
#124853   Can't wait to see what new "valuation" See SidVicious 05/27/16 11:19:26 AM
#124852   AMBS presenting but CEO's credibility is shot JPetroInc 05/27/16 11:17:28 AM
#124851   just who is in charge of AMBS JPetroInc 05/27/16 09:10:46 AM
#124849   It says ITS ONGOING as per the clinicaltrials website. newflow 05/26/16 07:04:30 PM
#124848   did you see Eltopra's Ph 2 results? JPetroInc 05/26/16 06:38:30 PM
#124847   ESS prize? No one knows what this means. newflow 05/26/16 06:19:53 PM
#124846   seems like there's still unlimited shares to sell JPetroInc 05/26/16 05:53:18 PM
#124844   get rid of them all Josh Sason - JPetroInc 05/26/16 06:58:56 AM
#124843   ESS strong buy calm61 05/26/16 05:06:32 AM
#124842   demand an independent accounting of AMBS's books JPetroInc 05/25/16 05:16:12 PM
#124841   Without substainable news, this R/S is wothless. GC sante1 05/25/16 01:57:37 PM
#124840   more like strong stench of cow dung. Just SidVicious 05/25/16 12:56:03 PM
#124839   Ambs - I agree strong buy now. Rocco!! 05/25/16 12:26:57 PM
#124838   Why is Gerald pumping the stock right before TopKnotchTrades 05/25/16 09:55:22 AM
#124837   Try the south of France. Harry von Zell 05/25/16 09:51:05 AM
#124836   look whose really looking for a new gig JPetroInc 05/25/16 07:06:07 AM
#124835   Does anyone know where I can find GC? sante1 05/24/16 10:50:00 PM
#124832   Gerald permanently threw his loyal shareholders to the JPetroInc 05/24/16 02:34:17 PM
#124830   P&D or revenue producing material event JPetroInc 05/24/16 12:54:10 PM
#124829   My technical analysis tells me a run is jjr04001 05/24/16 12:06:01 PM
#124828   as the new Owner (Josh Sason) JPetroInc 05/24/16 10:54:54 AM
#124827   Hey! How is that uplisting from strength strategy Shadowfaxin 05/24/16 09:51:21 AM
#124826   "We're uplisting from strength" JPetroInc 05/24/16 06:47:43 AM
#124825   THE Elephant in the room is not doing joboggi 05/24/16 04:13:51 AM
#124824   Buy and hold. AMBS strong buy$$$ calm61 05/24/16 01:28:00 AM
#124823   Buy and Hold!!!$$$$ Before you know it you'll a surfer 05/23/16 07:15:20 AM
#124822   so tell us who you do see JPetroInc 05/23/16 06:28:05 AM
#124821   I don't see Sasoon listed. IPO$ 05/22/16 09:01:13 PM
#124820   who is making the presentation on behalf of JPetroInc 05/22/16 07:40:27 PM
#124819   WHY JPetroInc 05/22/16 07:16:22 PM
#124817   this site was extremely helpful in getting bargain calm61 05/22/16 04:28:23 PM
#124816   AMBS IS STRONG BUY calm61 05/22/16 04:15:58 PM
#124815   definitely not calm61 05/22/16 04:14:22 PM
#124814   absolutly wrong calm61 05/22/16 04:13:36 PM
#124813   Oh I see it now. Disregard. IPO$ 05/22/16 03:49:02 PM
#124812   Nothing attached. IPO$ 05/22/16 03:47:34 PM
#124811   does this answer all your questions JPetroInc 05/22/16 03:11:44 PM
#124810   In what respect? More dilution from increased shares? IPO$ 05/22/16 01:56:15 PM
#124809   tell us again JPetroInc 05/22/16 01:28:06 PM
PostSubject